Published in J AAPOS on December 01, 2007
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis (2011) 1.87
Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol (2011) 1.28
Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis Study. Sci Med (Porto Alegre) (2010) 0.79
Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol (2013) 0.78
The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis. Mol Vis (2012) 0.77
Clinical Features and Risk Factors of Patients with Presumed Ocular Toxoplasmosis. J Ophthalmic Vis Res (2016) 0.75
Diagnosing the cause of bilateral paediatric cataracts: comparison of standard testing with a next-generation sequencing approach. Eye (Lond) (2016) 0.75
Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. Sci Rep (2017) 0.75
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics (1980) 3.21
Results of 20-year follow-up of congenital toxoplasmosis. Lancet (1986) 3.00
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis (2006) 2.63
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis (1994) 2.58
Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature (2003) 1.55
Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol (1996) 1.31
Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics (1995) 1.30
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics (2006) 1.10
Partial sight and blindness in children of the 1970 birth cohort at 10 years of age. J Epidemiol Community Health (1988) 1.09
Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol (2003) 0.99
Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology (2002) 0.97
Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report. J Pediatr (1973) 0.95
Clinicopathological features of a congenital murine model of ocular toxoplasmosis. Graefes Arch Clin Exp Ophthalmol (1986) 0.90
Congenital toxoplasmosis: eye manifestations in infants and children. Ann Trop Paediatr (2002) 0.88
Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study. J Glaucoma (2005) 0.87
Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr (2008) 4.33
Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med (2004) 2.83
Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol (2005) 2.66
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis (2006) 2.63
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 2.28
Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis (2012) 2.13
Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol (2005) 2.10
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis (2011) 1.87
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. Leuk Lymphoma (2007) 1.66
Effect of axial length and keratometry measurement error on intraocular lens implant power prediction formulas in pediatric patients. J AAPOS (2008) 1.64
Assessing the need for posterior sclerotomy at the time of filtering surgery in patients with Sturge-Weber syndrome. Ophthalmology (2003) 1.63
Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology (2007) 1.62
Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine (2010) 1.61
Toxoplasma gondii tachyzoite-bradyzoite interconversion. Trends Parasitol (2002) 1.58
Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am J Obstet Gynecol (2002) 1.50
What schools teach our patients about sex: content, quality, and influences on sex education. Obstet Gynecol (2008) 1.48
Reciprocal influences between girls' conduct problems and depression, and parental punishment and warmth: a six year prospective analysis. J Abnorm Child Psychol (2008) 1.46
NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect Immun (2010) 1.46
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol (2005) 1.46
Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz (2009) 1.45
Evolutionary origins of the eukaryotic shikimate pathway: gene fusions, horizontal gene transfer, and endosymbiotic replacements. Eukaryot Cell (2006) 1.44
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation (2008) 1.41
Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg (2003) 1.40
Social and emotional impact of strabismus surgery on quality of life in children. J AAPOS (2005) 1.39
Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2007) 1.39
Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med (2006) 1.34
P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol (2010) 1.33
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One (2008) 1.32
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol (2008) 1.30
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol (2008) 1.29
Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol (2011) 1.28
Women who remember, women who do not: a methodological study of maternal recall of smoking in pregnancy. Nicotine Tob Res (2009) 1.27
The shikimate pathway and its branches in apicomplexan parasites. J Infect Dis (2002) 1.25
Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J (2011) 1.25
Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand (2002) 1.23
Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. Br J Haematol (2007) 1.21
Neural larva migrans caused by the raccoon roundworm Baylisascaris procyonis. Pediatr Infect Dis J (2002) 1.14
Eye findings of diffuse unilateral subacute neuroretinitis and multiple choroidal infiltrates associated with neural larva migrans due to Bbaylisascaris procyonis. Am J Ophthalmol (2003) 1.13
Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm (2011) 1.13
Discrepancies between intraocular lens implant power prediction formulas in pediatric patients. Ophthalmology (2007) 1.11
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis (2008) 1.10
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics (2006) 1.10
Imaging of congenital toxoplasmosis macular scars with optical coherence tomography. Retina (2009) 1.10
Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis (2011) 1.09
Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase. Acta Crystallogr D Biol Crystallogr (2003) 1.09
Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A (2011) 1.09
Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology (2007) 1.09
Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome). J Am Acad Child Adolesc Psychiatry (2006) 1.08
Velo-cardio-facial syndrome. Curr Opin Pediatr (2005) 1.08
Intraocular lens power calculation in children. Surv Ophthalmol (2007) 1.07
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07
Use of hand-carried ultrasound devices to augment the accuracy of medical student bedside cardiac diagnoses. J Am Soc Echocardiogr (2005) 1.07
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway. Antimicrob Agents Chemother (2012) 1.07
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.06